Skip to main content

Table 3 Comparison between patients before and 12 weeks after EOT regarding FibroScan stages

From: Angiopoietin-2 as a predictor of fibrosis regression in chronic hepatitis C virus patients after direct-acting antiviral drugs

Fibrosis staging

Before treatment

12 weeks after treatment

MH

p

No.

%

No.

%

F0/1

14

35.0

23

57.5

32.0*

<0.001*

F2

11

27.5

8

20.0

F3

8

20.0

3

7.5

F4

7

17.5

6

15.0

  1. MH marginal homogeneity test, *significant